Nephrocare Health Services Ltd

Integrated Filing — Corporate Governance (NSE XBRL)

Company Home Dashboard NSE Viewer

Filing Summary

Company
Nephrocare Health Services Limited
Symbol
NEPHROPLUS
Quarter Ended
31-Mar-2026
Submission
Revision

General Disclosures

Additional Disclosure Date
17-Apr-2026
Additional Disclosure Designation
CFO
Additional Disclosure Name Of Signatory
Prashant Vinodkumar Goenka
Additional Disclosure Place
Hyderabad
Advertisements As Per Regulation471
Yes
Affirmations
All loans (or other form of debt), guarantees, comfort letters (by whatever name called) or securities in connection with any loan(s) (or other form of debt) given directly or indirectly by the listed entity to promoter(s), promoter group, director(s) (including their relatives), key managerial personnel (including their relatives) or any entity controlled by them are in the economic interest of the company.
Aggregate Amount Advanced During Six Months Of Any Loan Or Any Other Form Of Debt To KM Ps Or Any Other Entity Controlled By Them
0
Aggregate Amount Advanced During Six Months Of Any Loan Or Any Other Form Of Debt To Promoter Group Or Any Other Entity Controlled By Them
0
Aggregate Amount Advanced During Six Months Of Any Loan Or Any Other Form Of Debt To Promoter Or Any Other Entity Controlled By Them
0
Aggregate Amount Of Issuance During Six Months Of Any Guarantee Or Comfort To KM Ps Or Any Other Entity Controlled By Them
0
Aggregate Amount Of Issuance During Six Months Of Any Guarantee Or Comfort To Promoter Group Or Any Other Entity Controlled By Them
0
Aggregate Amount Of Issuance During Six Months Of Any Guarantee Or Comfort To Promoter Or Any Other Entity Controlled By Them
0
Aggregate Value Of Security Provided During Six Months Of Security In Connection With Loan Or Any Other Debt Avail By KM Ps Or Any Other Entity Controlled By Them
0
Aggregate Value Of Security Provided During Six Months Of Security In Connection With Loan Or Any Other Debt Avail By Promoter Group Or Any Other Entity Controlled By Them
0
Aggregate Value Of Security Provided During Six Months Of Security In Connection With Loan Or Any Other Debt Avail By Promoter Or Any Other Entity Controlled By Them
0
Annual Return As Provided Under Section92Of The Companies Act2013
Yes
Approval For Material Related Party Transactions
Yes
Approval Of The Board And Shareholders For Compensation Or Profit Sharing
Not Applicable
Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls
Yes
Balance Outstanding At The End Of Six Months Any Loan Or Any Other Form Of Debt To KM Ps Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Any Loan Or Any Other Form Of Debt To Promoter Group Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Any Loan Or Any Other Form Of Debt To Promoter Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Any Guarantee Or Comfort To KM Ps Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Any Guarantee Or Comfort To Promoter Group Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Any Guarantee Or Comfort To Promoter Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Security In Connection With Loan Or Any Other Debt Avail By KM Ps Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Security In Connection With Loan Or Any Other Debt Avail By Promoter Group Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Security In Connection With Loan Or Any Other Debt Avail By Promoter Or Any Other Entity Controlled By Them
0
Board Composition
Yes
Code Of Conduct
Yes
Compliance Certificate
Yes
Compliance Status
Yes
Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation
Yes
Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46
Yes
Credit Rating Or Revision In Credit Rating Obtained
Yes
Date Of End Of Financial Year
31-Mar-2026
Date Of End Of Reporting Period
31-Mar-2026
Date Of Signing
17-Apr-2026
Date Of Start Of Financial Year
01-Apr-2025
Designation Of Person
Company Secretary and Compliance Officer
Designation Of Person Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Annual Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Quartely Affirmations
Company Secretary and Compliance Officer
Details Of Agreements Entered Into With The Media Companies And Or Their Associates
Not Applicable
Details Of Business
Yes
Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy
Yes
Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30
Yes
Disclosure Of Notes On Website In Terms Of Listing Regulations Explanatory Text Block
Secretarial Compliance Report for financial year ended 31 March 2026 will be uploaded on website once filed with Exchanges.
Disclosure Of Related Party Transactions On Consolidated Basis
Yes
Disclosure Web Link Of Annual Return As Provided Under Section92Of The Companies Act2013Is Placed
https://nephroplus.com/api/assets/investors/disclosures-under-reg-46/annual-returns/NP_Certified_MGT-7_FY25.pdf
Disclosure Web Link Of Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls Is Placed
https://nephroplus.com/investors
Disclosure Web Link Of Company At Advertisements As Per Regulation471Is Placed
https://nephroplus.com/api/assets/investors/disclosures-under-reg-46/board-meeting/2025-26/FE_e_paper_merged_1.pdf
Disclosure Web Link Of Company At Details Of Non Compliance Of New Name And The Old Name Of The Listed Entity Is Placed
https://nephroplus.com/investors
Disclosure Web Link Of Company At Dividend Distribution Policy As Per Regulation43A1Is Placed
https://nephroplus.com/api/assets/investors/disclosures-under-reg-46/policies-and-code-of-conduct/NP_Dividend_Distribution_Policy-Signed.pdf
Disclosure Web Link Of Company At Materiality Policy As Per Sub Regulation4Regulation30Is Placed
https://nephroplus.com/api/assets/investors/disclosures-under-reg-46/policies-and-code-of-conduct/NP_Materiality_Policy.pdf
Disclosure Web Link Of Company At Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity Is Placed
https://nephroplus.com/investors
Disclosure Web Link Of Company At Which Credit Rating Or Revision In Credit Rating Obtained Is Placed
https://nephroplus.com/api/assets/investors/disclosures-under-reg-46/credit-rating-updates/Nephrocare_Health_Services_Limited_-_Edited_RAC_1.pdf
Disclosure Web Link Of Company At Which Details Of Business Is Placed
https://nephroplus.com/investors
Disclosure Web Link Of Company At Which Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy Is Placed
https://nephroplus.com/api/assets/investors/disclosures-under-reg-46/policies-and-code-of-conduct/NP_Whistle_Blower_Policy_1.pdf
Disclosure Web Link Of Company At Which Financial Results Is Placed
https://nephroplus.com/api/assets/investors/financials/quarterly-financials/fy-2025-26/Financial_Results_Q3FY26.pdf
Disclosure Web Link Of Company At Which Policy For Determining Material Subsidiaries Is Placed
https://nephroplus.com/api/assets/investors/disclosures-under-reg-46/policies-and-code-of-conduct/NP_Policy-for-Determining-Materiality-Subsidiaries.pdf
Disclosure Web Link Of Company At Which Policy On Dealing With Related Party Transactions Is Placed
https://nephroplus.com/api/assets/investors/disclosures-under-reg-46/policies-and-code-of-conduct/NP_RPT_Policy.pdf
Disclosure Web Link Of Company At Which Shareholding Pattern Is Placed
https://nephroplus.com/api/assets/investors/disclosures-under-reg-46/shareholding-pattern/2025-26/SHP_as_on_31.12.2025_1.pdf
Disclosure Web Link Of Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation Is Placed
https://nephroplus.com/investors
Disclosure Web Link Of Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46Is Placed
https://nephroplus.com/investors
Disclosure Web Link Of Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30Is Placed
https://nephroplus.com/api/assets/investors/disclosures-under-reg-46/stock-exchange-disclosures/2025-26/Disclosure_under_Reg_305_Authorising_official_for_disclosure_of_Materiality.pdf
Disclosure Web Link Of Disclosures Under Sub Regulation8Of Regulation30Is Placed
https://nephroplus.com/investors
Disclosure Web Link Of Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021Is Placed
https://nephroplus.com/api/assets/investors/disclosures-under-reg-46/policies-and-code-of-conduct/ESOP_Scheme_2011.pdf
Disclosure Web Link Of Memorandum Of Association And Articles Of Association Is Placed
https://nephroplus.com/api/assets/investors/disclosures-under-reg-46/moa-and-aoa/Memorandum_and_Articles_of_Association.pdf
Disclosure Web Link Of Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet Is Placed
https://nephroplus.com/api/assets/investors/disclosures-under-reg-46/investors-analysts-meet/2025-26/Reg30InvPresentationdt10022026.pdf
Disclosure Web Link Of Statements Of Deviations Or Variations As Specified In Regulation32Is Placed
https://nephroplus.com/api/assets/investors/disclosures-under-reg-46/board-meeting/2025-26/DisclosureofMonitoringAgencyReportdt1202026.pdf
Disclosures Under Sub Regulation8Of Regulation30
Yes
Dividend Distribution Policy As Per Regulation43A1
Yes
Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021
Yes
Fees Or Compensation
Yes
Financial Results
Yes
Is SCORESID Available
Yes
ISIN
INE428V01029
Market Capitalisation As Per Immediate Previous Financial Year
Any other
Materiality Policy As Per Sub Regulation4Regulation30
Yes
Memorandum Of Association And Articles Of Association
Yes
Minimum Information
Yes
MSEI Symbol
Not Applicable
Name Of Signatory
Kishore Kathri
Name Of Signatory Affirmations
Kishore Kathri
Name Of Signatory For Annual Affirmations
Kishore Kathri
Name Of Signatory For Quartely Affirmations
Kishore Kathri
Name Of The Company
Nephrocare Health Services Limited
New Name And The Old Name Of The Listed Entity
Yes
Other Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity
Yes
Place
Hyderabad
Plans For Orderly Succession For Appointments
Not Applicable
Policy For Determining Material Subsidiaries
Yes
Policy For Related Party Transaction
Yes
Policy On Dealing With Related Party Transactions
Yes
Recommendation Of Board
Yes
Reporting Quarter
Yearly
Review Of Compliance Reports
Yes
Risk Assessment And Management
Yes
Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet
Yes
SCORES Registration ID
comn00616
Scrip Code
544647
Secretarial Compliance Report
Not Applicable
Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity
Yes
Shareholding Pattern
Yes
Statements Of Deviations Or Variations As Specified In Regulation32
Yes
Symbol
NEPHROPLUS
The Listed Entity Has Approved Material Subsidiary Policy And The Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity Have Been Complied
Yes
Type Of Any Guarantee Or Comfort Letter Of KM Ps Or Any Other Entity Controlled By Them
Nil
Type Of Any Guarantee Or Comfort Letter Of Promoter Group Or Any Other Entity Controlled By Them
Nil
Type Of Any Guarantee Or Comfort Letter Of Promoter Or Any Other Entity Controlled By Them
Nil
Type Of Company
Equity
Type Of Security Of KM Ps Or Any Other Entity Controlled By Them
Nil
Type Of Security Of Promoter Group Or Any Other Entity Controlled By Them
Nil
Type Of Security Of Promoter Or Any Other Entity Controlled By Them
Nil
Type Of Submission
Original
Vacancies In Respect Key Managerial Personnel
Not Applicable
Vigil Mechanism
Yes
Whether As Per Sub Regulation2ba Of Regulation27Of SEBILODR There Has Been Cyber Security Incidents During The Quarter
No
Whether Part A Of Annexure I Of The SEBI Circular Dated31December2024Related To Compliance Report On Corporate Governance Is Applicable To The Entity
Yes
Whether Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Applicable To The Entity
Yes

Additional Disclosures

Entry D_MeetingBOD1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD10
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD11
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD5
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD6
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD7
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD8
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD9
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit5
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit6
Whether Requirement Of Quorum Met
Yes
Official NSE disclosure viewer

If the viewer does not load, use the NSE Viewer button above to open it in a new tab.

Board Composition — Entity Disclosures

The Composition Of Board Of Directors Is In Terms Of Sebi Regulations2015
Yes
Chairperson Related to MD / CEO
Yes
Regular Chairperson
Yes

Composition of Board of Directors

SrTitleDirectorPANDINCategory 1Category 2Category 3Date of BirthDisqualifiedStatusSpecial ResolutionInitial AppointmentRe-appointmentTenure (months)Listed DirectorshipsIndependent DirectorshipsAudit / Stakeholder MembershipsAudit / Stakeholder Chair Posts
1MrVikram Vuppala******02847323Executive DirectorChairperson related to PromoterMD14-Dec-1976NoActiveNot Applicable18-Dec-200916-Jul-20251010
2MrVishal Vijay Gupta******01913013Non-Executive - Nominee DirectorNot Applicable24-Sep-1977NoActiveNo10-Oct-201410-Oct-2014137.211010
3MrGaurav Sharma******03311656Non-Executive - Nominee DirectorNot Applicable28-Feb-1972NoActiveNo27-Nov-201927-Nov-201976.41011
4MrSunil Kumar Thakur******03266370Non-Executive - Nominee DirectorNot Applicable03-Feb-1978NoActiveNo08-May-202408-May-202422.232010
5MrOm Prakash Manchanda******02099404Non-Executive - Independent DirectorNot Applicable30-Aug-1965NoActiveNo11-Feb-202111-Feb-202661.22220
6MrHemant Sultania******00472577Non-Executive - Independent DirectorNot Applicable11-Jul-1972NoActiveNo18-Jun-202218-Jun-202242.011111
7MsAnnette Berit Ingrid Kumlien******11050620Non-Executive - Independent DirectorNot Applicable14-Apr-1965NoActiveNo12-May-202512-May-202519-Oct-20261110
8MrAjay Bakshi******05254187Non-Executive - Independent DirectorNot Applicable25-Nov-1968NoActiveNo12-May-202512-May-202519-Oct-20261100

Committee Disclosures

Entry CompComit100
Date of Appointment
20-Mar-2026
Entry CompComit101
Date of Appointment
20-Mar-2026
Entry CompComit122
Date of Appointment
02-Jul-2025
Entry CompComit123
Date of Appointment
02-Jul-2025
Entry CompComit124
Date of Appointment
02-Jul-2025
Entry CompComit14
Date of Appointment
02-Jul-2025
Entry CompComit15
Date of Appointment
02-Jul-2025
Entry CompComit16
Date of Appointment
02-Jul-2025
Entry CompComit41
Date of Appointment
02-Jul-2025
Entry CompComit42
Date of Appointment
02-Jul-2025
Entry CompComit43
Date of Appointment
02-Jul-2025
Entry CompComit68
Date of Appointment
02-Jul-2025
Entry CompComit69
Date of Appointment
02-Jul-2025
Entry CompComit70
Date of Appointment
02-Jul-2025
Entry CompComit95
Date of Appointment
02-Jul-2025
Entry CompComit96
Date of Appointment
02-Jul-2025
Entry CompComit97
Date of Appointment
02-Jul-2025
Entry CompComit98
Date of Appointment
20-Mar-2026
Entry CompComit99
Date of Appointment
20-Mar-2026
Entry MainD
Composition And Role Of Risk Management Committee
Yes
Composition Of Audit Committee
Yes
Composition Of Nomination And Remuneration Committee
Yes
Composition Of Stakeholder Relationship Committee
Yes
Composition Of Various Committees Of Board Of Directors
Yes
Disclosure Web Link Of Company At Which Composition Of Various Committees Of Board Of Directors Is Placed
https://nephroplus.com/investors
Memberships In Committees
Yes
Prior Or Omnibus Approval Of Audit Committee For All Related Party Transactions
Yes
Risk Management Committee
No
Role Of Audit Committee And Information To Be Reviewed By The Audit Committee
Yes
Role Of Nomination And Remuneration Committee
Yes
Role Of Stakeholders Relationship Committee
Yes
The Committee Members Have Been Made Aware Of Their Powers Role And Responsibilities As Specified In Sebi Regulations2015
Yes
The Composition Of Audit Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Nomination And Remuneration Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Risk Management Committee Is In Terms Of Sebi Regulations2015
Not Applicable
The Composition Of The Stakeholders Relationship Committee Committee Is In Terms Of Sebi Regulations2015
Yes
Whether The Audit Committee Has A Regular Chairperson
Yes
Whether The Corporate Social Responsibility Committee Has A Regular Chairperson
Yes
Whether The Nomination And Remuneration Committee Has A Regular Chairperson
Yes
Whether The Risk Management Committee Has A Regular Chairperson
Yes
Whether The Stakeholders Relationship Committee Has A Regular Chairperson
Yes

Audit Committee

Additional Position
Chairperson
Director DIN
00472577
Member Name
Hemant Sultania
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
01913013
Member Name
Vishal Vijay Gupta
Position
Non-Executive - Nominee Director

Audit Committee

Additional Position
Member
Director DIN
11050620
Member Name
Annette Berit Ingrid Kumlien
Position
Non-Executive - Independent Director

Audit Committee

Audit Committee

Audit Committee

Audit Committee

Corporate Social Responsibility Committee

Additional Position
Chairperson
Director DIN
02847323
Member Name
Vikram Vuppala
Position
Executive Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
03266370
Member Name
Sunil Kumar Thakur
Position
Non-Executive - Nominee Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
05254187
Member Name
Ajay Bakshi
Position
Non-Executive - Independent Director

Corporate Social Responsibility Committee

Nomination and remuneration committee

Additional Position
Chairperson
Director DIN
02099404
Member Name
Om Prakash Manchanda
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
03266370
Member Name
Sunil Kumar Thakur
Position
Non-Executive - Nominee Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
05254187
Member Name
Ajay Bakshi
Position
Non-Executive - Independent Director

Other Committee

Additional Position
Chairperson
Director DIN
02847323
Member Name
Vikram Vuppala
Name Of Other Committee
IPO Committee
Position
Executive Director

Other Committee

Additional Position
Member
Director DIN
01913013
Member Name
Vishal Vijay Gupta
Name Of Other Committee
IPO Committee
Position
Non-Executive - Nominee Director

Other Committee

Additional Position
Member
Director DIN
03311656
Member Name
Gaurav Sharma
Name Of Other Committee
IPO Committee
Position
Non-Executive - Nominee Director

Other Committee

Additional Position
Member
Director DIN
03266370
Member Name
Sunil Kumar Thakur
Name Of Other Committee
IPO Committee
Position
Non-Executive - Nominee Director

Risk Management Committee

Additional Position
Member
Director DIN
05254187
Member Name
Ajay Bakshi
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
03266370
Member Name
Sunil Kumar Thakur
Position
Non-Executive - Nominee Director

Risk Management Committee

Additional Position
Chairperson
Director DIN
02847323
Member Name
Vikram Vuppala
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
00472577
Member Name
Hemant Sultania
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
99999999
Member Name
Prashant Goenka
Position
Chief Financial Officer

Risk Management Committee

Additional Position
Member
Director DIN
99999999
Member Name
Rohit Singh
Position
Chief Executive Officer

Risk Management Committee

Additional Position
Member
Director DIN
11050620
Member Name
Annette Berit Ingrid Kumlien
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Chairperson
Director DIN
03311656
Member Name
Gaurav Sharma
Position
Non-Executive - Nominee Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
02847323
Member Name
Vikram Vuppala
Position
Executive Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
02099404
Member Name
Om Prakash Manchanda
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Entry MainD
Gap Between The Meetings Of The Risk Management Committee
Not Applicable
Meeting Of Audit Committee
Yes
Meeting Of Board Of Directors
Yes
Meeting Of Independent Directors
Yes
Meeting Of Nomination And Remuneration Committee
Yes
Meeting Of Risk Management Committee
Not Applicable
Meeting Of Stakeholders Relationship Committee
Yes
Quorum Of Board Meeting
Yes
Quorum Of Nomination And Remuneration Committee Meeting
Yes
Quorum Of Risk Management Committeemeeting
Not Applicable
The Meetings Of The Board Of Directors And The Above Committees Have Been Conducted In The Manner As Specified In Sebi Regulations2015
Yes
Entry MeetingBOD1
Dates Of Meeting In The Previous Quarter
19-Nov-2025
Number Of Directors Present In Meeting Of Board Of Directors
7
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingBOD10
Dates Of Meeting If Any In The Relevant Quarter
10-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
25
Number Of Directors Present In Meeting Of Board Of Directors
8
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingBOD11
Dates Of Meeting If Any In The Relevant Quarter
20-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
37
Number Of Directors Present In Meeting Of Board Of Directors
8
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingBOD2
Dates Of Meeting In The Previous Quarter
20-Nov-2025
Maximum Gap Between Any Two Consecutive Meetings
0
Number Of Directors Present In Meeting Of Board Of Directors
5
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingBOD3
Dates Of Meeting In The Previous Quarter
02-Dec-2025
Maximum Gap Between Any Two Consecutive Meetings
11
Number Of Directors Present In Meeting Of Board Of Directors
6
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingBOD4
Dates Of Meeting In The Previous Quarter
03-Dec-2025
Maximum Gap Between Any Two Consecutive Meetings
0
Number Of Directors Present In Meeting Of Board Of Directors
6
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingBOD5
Dates Of Meeting In The Previous Quarter
09-Dec-2025
Maximum Gap Between Any Two Consecutive Meetings
5
Number Of Directors Present In Meeting Of Board Of Directors
7
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingBOD6
Dates Of Meeting In The Previous Quarter
12-Dec-2025
Maximum Gap Between Any Two Consecutive Meetings
2
Number Of Directors Present In Meeting Of Board Of Directors
7
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingBOD7
Dates Of Meeting In The Previous Quarter
15-Dec-2025
Maximum Gap Between Any Two Consecutive Meetings
2
Number Of Directors Present In Meeting Of Board Of Directors
6
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingBOD8
Dates Of Meeting If Any In The Relevant Quarter
05-Jan-2026
Maximum Gap Between Any Two Consecutive Meetings
20
Number Of Directors Present In Meeting Of Board Of Directors
5
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingBOD9
Dates Of Meeting If Any In The Relevant Quarter
15-Jan-2026
Maximum Gap Between Any Two Consecutive Meetings
9
Number Of Directors Present In Meeting Of Board Of Directors
7
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingComit1
Dates Of Meeting Of The Committee In The Previous Quarter
19-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
2
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
7
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit2
Dates Of Meeting Of The Committee In The Previous Quarter
20-Nov-2025
Maximum Gap Between Any Two Consecutive Meetings
0
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
2
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
3
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit3
Dates Of Meeting Of The Committee In The Previous Quarter
02-Dec-2025
Maximum Gap Between Any Two Consecutive Meetings
11
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
2
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
2
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit4
Dates Of Meeting Of The Committee In The Relevant Quarter
10-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
69
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
6
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit5
Dates Of Meeting Of The Committee In The Relevant Quarter
10-Feb-2026
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
3
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit6
Dates Of Meeting Of The Committee In The Relevant Quarter
10-Feb-2026
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
2
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
4
Total Number Of Directors As On Date Of The Meeting
3
Entry MainD
Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances
Yes
Disclosure Web Link Of Company At Which Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances Is Placed
https://nephroplus.com/investors
Disclosure Web Link Of Company At Which Email Address For Grievance Redressal And Other Relevant Details Is Placed
[email protected]
Email Address For Grievance Redressal And Other Relevant Details
Yes
No Of Investor Complaints Disposed Off During The Period
2
No Of Investor Complaints During The Period
0
No Of Investor Complaints Received During The Period
2
Whether Part B Of Annexure I Of The SEBI Circular Dated31December2024Related To Investor Grievance Redressal Report Is Applicable To The Entity
Yes
Entry MainI
No Of Investor Complaints
0
Entry PY_I
No Of Investor Complaints
0
Composition Of Board Of Directors Of Unlisted Material Subsidiary
Yes
Whether Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Applicable To The Entity
Yes
Entry I_OngoingTaxLitigationsOrDisputes1
Current Status
The order rejecting the rectification application was received on 06 March 2026. Thereafter, an appeal against the Order-in-Original (OIO) dated 13 January 2025 was filed before the Deputy Commissioner (Appeals), Kashmir on 07 March 2026, which was rejected on 12 March 2026. Consequently, a writ petition has been filed before the Hon'ble High Court of Jammu & Kashmir and Ladakh at Srinagar on 02nd April 2026, WP(C) 646/2026. The first hearing was held on 03 April 2026, and the matter has been adjourned to 17 April 2026, as the learned Assisting Counsel has been granted two weeks’ time for filing the response.
Date of Initiation
13-Jan-2025
Opposing Party
State Tax Officer, Jammu and Kashmir.
Status (Previous Disclosure)
An application for rectification of the demand order relating to FY 2020-21 was filed on 24 May 2025. The matter is currently pending for action by the concerned Tax Officer, and no order has been passed as on date.
Entry I_OngoingTaxLitigationsOrDisputes2
Current Status
A Show Cause Notice (SCN) in Form DRC-01 has been issued on 19 March 2026 in relation to the aforementioned DRC-01A. The reply to the said SCN is yet to be filed the due date for submission is 19 April 2026.
Date of Initiation
06-Nov-2025
Opposing Party
Asst. Commissioner of Revenue, West Bengal
Status (Previous Disclosure)
Intimation in Form GST DRC-01A was issued for FY 2023-24. The reply to the said intimation is pending to be filed.
Entry MainD
Whether Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Applicable To The Entity
Yes
Entry I_ImpositionOfFineOrPenalty1
Authority
Reserve Bank of India – Hyderabad Regional Office
Date Of Receipt Of Direction Or Order Including Any Ad Interim Or Interim Orders Or Any Other Communication From The Authority
25-Feb-2026
Financial / Operational Impact
Financial impact limited to compounding amount of ₹2,86,995, which has duly been paid. No material impact on operations or other activities.
Nature And Details Of The Action Taken Or Order Passed
The order relates to compounding of contraventions under FEMA by Nephrocare Health Services Limited for delays in FDI-related reporting, including FC-GPR, FC-TRS and FLA filings. The contraventions are procedural in nature arising from delayed submissions. The matter has been regularised upon payment of the compounding amount. - The amount mentioned in the said order was duly paid on 1st March, 2026
Violation Details
Non-compliance with prescribed timelines for FDI reporting, including: Delay in reporting receipt of foreign inward remittances Delay in reporting allotment of shares to non-residents (FC-GPR) Delay in reporting transfer of shares between resident and non-resident (FC-TRS) Delay in filing Annual Return on Foreign Liabilities and Assets (FLA) for multiple years
Entry I_ImpositionOfFineOrPenalty2
Authority
Reserve Bank of India – Hyderabad Regional Office
Date Of Receipt Of Direction Or Order Including Any Ad Interim Or Interim Orders Or Any Other Communication From The Authority
23-Feb-2026
Financial / Operational Impact
Financial impact limited to payment of LSF amounting to ₹8,700 (including fixed component of ₹7,500) which has duly been paid; no material operational impact
Nature And Details Of The Action Taken Or Order Passed
Levy of Late Submission Fee (LSF) for delayed filing of Form FC-TRS (Ref No. FC_TRS0226116095) - LSF as advised has been duly paid on 24th February, 2026
Violation Details
Delay in filing Form FC-TRS under FEMA regulations
Entry I_ImpositionOfFineOrPenalty3
Authority
Reserve Bank of India – Hyderabad Regional Office
Date Of Receipt Of Direction Or Order Including Any Ad Interim Or Interim Orders Or Any Other Communication From The Authority
23-Feb-2026
Financial / Operational Impact
Financial impact limited to payment of LSF amounting to ₹22,300 (including fixed component of ₹7,500) which has duly been paid; no material operational impact
Nature And Details Of The Action Taken Or Order Passed
Levy of Late Submission Fee (LSF) for delayed filing of Form FC-TRS (Ref No. FC_TRS0226116088) - LSF as advised has been duly paid on 24th February, 2026
Violation Details
Delay in filing Form FC-TRS under FEMA regulations
Entry MainD
Whether Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Applicable To The Entity
Yes